Popular Articles

Critical Outcome Technologies Inc. Announces The Launch Of A Drug Discovery Program For Alzheimer's Disease
Critical Outcome Technologies Inc. (COTI)(TSX VENTURE:COT), announced that the Company has undertaken the discovery and optimization of novel lead compounds for the treatment of Alzheimer"s Disease (AD). "Based on partnering interest expressed by multiple global pharmaceutical organizations we have decided to establish a drug discovery program to help combat this devastating disease", said Mr. Michael Cloutier, Chief Executive Officer of COTI.
pharmacy online
Possible Treatment For Spinal Muscular Atrophy
Spinal Muscular Atrophy is the second-leading cause of infant mortality in the world.
News of the day
Body Chemistry May Identify Type 2 Risk, UK
Body chemistry changes that lead to Type 2 diabetes begin several years before symptoms become apparent, according to new research.
Diagnostics

The Mood Of Depressed People Improves With Weight Loss

Research to be presented at the Annual Meeting of the Society for the Study of Ingestive Behavior (SSIB), July 28 - August 1, 2009, the foremost society for research into all aspects of eating and drinking behavior, finds that after a 6-month behavioral weight loss program, depressed patients not only lost 8% of their initial weight but also reported significant improvements in their symptoms of depression, as well as reductions in triglycerides, which are a risk factor for heart disease and stroke. The results of this study highlight the need for further research into the effects of weight loss in individuals suffering from psychiatric disorders. "This research is novel because clinically depressed individuals are not usually included in weight loss trials due to concerns that weight loss could worsen their depression," said Dr. Lucy Faulconbridge, lead author of the study. "These concerns, however, are not based on empirical evidence, and the practice of excluding depressed individuals from clinical weight loss trials means that we are learning nothing about this high-risk population." The latest findings suggest that depressed, obese individuals can indeed lose clinically significant amounts of weight, and that weight loss can actually reduce symptoms of depression. Fifty-one depressed and non-depressed subjects were recruited into the study to follow a supervised weight loss program that included lifestyle modification and meal replacements. Both depressed and non-depressed subjects lost significant amounts of weight, with depressed individuals losing 8% of their initial body weight, compared with 11% loss by non-depressed individuals. After 6 months on the weight loss program, depressed subjects also showed significant improvement of their depressive symptoms, based on a questionnaire. Additional significant improvements in glucose, insulin and high density lipoprotein (HDL) cholesterol were observed in both depressed and non-depressed subjects, and depressed individuals showed reduced levels of triglycerides in the blood, which have been linked to risk of heart disease and stroke. "Depression and obesity are independently associated with increased risk of heart disease and stroke, and so reductions in both body weight and symptoms of depression are likely to improve long-term health outcomes" said Faulconbridge. Supported by NIDDK:DK069652-04 and National Institute of Health Lead author: Lucy Faulconbridge, University of Pennsylvania School of Medicine, Philadelphia, PA, USA Co-authors: TA WADDEN, LS JONES-CORNEILLE, DB SARWER, M PULCINI, L BERGELSON. University of Pennsylvania School of Medicine, Philadelphia, PA, USA Jamie Price Society for the Study of Ingestive Behavior


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):